Head and Neck Neoplasms
, 2.0 mg/mL, 0.5 mg/mL, 4.0 mg/mL, 20.0 mg, 5.0 mg, 0.2 mg/mL, 40.0 mg
Intravenous, , Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intravenous; Intravesical, Powder, for solution, Powder, for solution - Intravenous; Intravesical, Kit, Solution - Ophthalmic, Ophthalmic, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Ureteral, Kit - Ophthalmic
Glaucoma
, 2.0 mg/mL, 0.5 mg/mL, 4.0 mg/mL, 20.0 mg, 5.0 mg, 0.2 mg/mL, 40.0 mg
Intravenous, , Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intravenous; Intravesical, Powder, for solution, Powder, for solution - Intravenous; Intravesical, Kit, Solution - Ophthalmic, Ophthalmic, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Ureteral, Kit - Ophthalmic
Mesothelioma
, 2.0 mg/mL, 0.5 mg/mL, 4.0 mg/mL, 20.0 mg, 5.0 mg, 0.2 mg/mL, 40.0 mg
Intravenous, , Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intravenous; Intravesical, Powder, for solution, Powder, for solution - Intravenous; Intravesical, Kit, Solution - Ophthalmic, Ophthalmic, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Ureteral, Kit - Ophthalmic
Breast Cancer
, 2.0 mg/mL, 0.5 mg/mL, 4.0 mg/mL, 20.0 mg, 5.0 mg, 0.2 mg/mL, 40.0 mg
Intravenous, , Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intravenous; Intravesical, Powder, for solution, Powder, for solution - Intravenous; Intravesical, Kit, Solution - Ophthalmic, Ophthalmic, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Ureteral, Kit - Ophthalmic
Gastric Adenocarcinoma
, 2.0 mg/mL, 0.5 mg/mL, 4.0 mg/mL, 20.0 mg, 5.0 mg, 0.2 mg/mL, 40.0 mg
Intravenous, , Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intravenous; Intravesical, Powder, for solution, Powder, for solution - Intravenous; Intravesical, Kit, Solution - Ophthalmic, Ophthalmic, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Ureteral, Kit - Ophthalmic
Non-Small Cell Lung Cancer
, 2.0 mg/mL, 0.5 mg/mL, 4.0 mg/mL, 20.0 mg, 5.0 mg, 0.2 mg/mL, 40.0 mg
Intravenous, , Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intravenous; Intravesical, Powder, for solution, Powder, for solution - Intravenous; Intravesical, Kit, Solution - Ophthalmic, Ophthalmic, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Ureteral, Kit - Ophthalmic
Anus Neoplasms
, 2.0 mg/mL, 0.5 mg/mL, 4.0 mg/mL, 20.0 mg, 5.0 mg, 0.2 mg/mL, 40.0 mg
Intravenous, , Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intravenous; Intravesical, Powder, for solution, Powder, for solution - Intravenous; Intravesical, Kit, Solution - Ophthalmic, Ophthalmic, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Ureteral, Kit - Ophthalmic
Bladder Cancer
, 2.0 mg/mL, 0.5 mg/mL, 4.0 mg/mL, 20.0 mg, 5.0 mg, 0.2 mg/mL, 40.0 mg
Intravenous, , Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intravenous; Intravesical, Powder, for solution, Powder, for solution - Intravenous; Intravesical, Kit, Solution - Ophthalmic, Ophthalmic, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Ureteral, Kit - Ophthalmic
Pancreatic Adenocarcinoma
, 2.0 mg/mL, 0.5 mg/mL, 4.0 mg/mL, 20.0 mg, 5.0 mg, 0.2 mg/mL, 40.0 mg
Intravenous, , Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intravenous; Intravesical, Powder, for solution, Powder, for solution - Intravenous; Intravesical, Kit, Solution - Ophthalmic, Ophthalmic, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Ureteral, Kit - Ophthalmic
low-grade Upper Tract Urothelial Cancer (LG-UTUC)
, 2.0 mg/mL, 0.5 mg/mL, 4.0 mg/mL, 20.0 mg, 5.0 mg, 0.2 mg/mL, 40.0 mg
Intravenous, , Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Intravenous; Intravesical, Powder, for solution, Powder, for solution - Intravenous; Intravesical, Kit, Solution - Ophthalmic, Ophthalmic, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Ureteral, Kit - Ophthalmic